benlysta popular tagged News at allvoices.com

benlysta news

News tagged with “benlysta”. Found: 51 tagged news reports.
 

Your Search Returned 51 tagged news reports

 
Related Tags:

United Kingdom :: United Kingdom | 9 months ago

Credibility Credibility of 5

GlaxoSmithKline's (GSK) belimumab (Benlysta) as an add-on therapy in adults with active, autoantibody-positive systemic lupus erythematosus (SLE). Sir Andrew Dillon said the independent appraisal committee doesn't recommend belimumab because the

Tags:

Bangalore :: India | over 1 year ago

Credibility Credibility of 5

Biotechnology company Biogen Idec sold its royalty rights on the lupus treatment Benlysta to Canadian investment firm DRI Capital Inc in exchange for a multiple of the royalty amount it was due to receive over three years. Human Genome Sciences and

Tags:

London :: United Kingdom | almost 2 years ago

Credibility Credibility of 5

Jordo is a member of The Motley Fool Blog Network -- entries represent the personal opinions of our bloggers and are not formally edited. SLE) treatment.  The company has made it abundantly clear that it is open to purchase offers.  Tom Watkins,

Tags:

London :: United Kingdom | almost 2 years ago

Credibility Credibility of 5

The biotechnology buyout binge continued this week, driving profits for those investing in biotech stocks ...Human Genome argued the unsolicited bid did not reflect the company's inherent value. GSK adamantly insisted its bid, an 81% premium when

Tags:

Alexandria :: VA :: USA | almost 2 years ago

Credibility Credibility of 5

last week, management figured it would be a good venue to state its case. It's not often you hear a CEO on an earnings call say, "We do not plan to take you through the financial results in today's call." What's really interesting is that I don't

Tags:

New York City :: NY :: USA | almost 2 years ago

Credibility Credibility of 5

Content Signage is pictured on the company  Human Genome said it would not comment on the process, but reiterated that Glaxo 's $13 per share offer was not sufficient and failed to account for the inherent value of the company's pharmaceutical assets.

Tags:

Alexandria :: VA :: USA | almost 2 years ago

Credibility Credibility of 5

Human Genome Sciences is partnered with Glaxo on their lupus drug Benlysta and has licensed a few other drugs to the pharma giant. The $13-per-share offer was flat-out rejected by Human Genome Sciences' board, but the board figured it should see if

Tags:

Alexandria :: VA :: USA | 2 years ago

Credibility Credibility of 5

Currently, its main focus is on drugs that treat renal disease and cancer. It has two drugs in  phase 3 trials : Zerenex (ferric citrate), which is an oral, iron-based compound used to treat patients with end-stage renal disease, and KRX-0401 (

Tags:

Mumbai :: India | 2 years ago

Credibility Credibility of 5

Stocks to Get on Your Watchlist Watch stocks you care about The single, easiest way to keep track of all the stocks that matter.....I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. Without my watchlist,

Tags:

Boston :: MA :: USA | 2 years ago

Credibility Credibility of 5

Articles In an industry steeped in complex research and speculative drug development, successful biotech investing requires real sophistication. Senior Biotechnology Analyst Carol Werther of Boston-based Summer Street Research Partners brings her

Tags:



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.